SCHEMBL30427352

SCHEMBL30427352

Cc1cc(NC2CC(C)(O)C2)nnc1-c1ccc(C#N)cc1O

nearest known ligand 0.71

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IL1B P01584 9/20 0.71
TNF P01375 1/20 0.67
NLRP3 Q96P20 10/20 0.67
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25195389 1.00 IL1B (0.71) IL1BTNFNLRP3KCNH2
SCHEMBL25854958 0.89 IL1B (0.71) IL1BTNFNLRP3
SCHEMBL25861500 0.89 IL1B (0.71) IL1BTNFNLRP3
SCHEMBL25258966 0.89 IL1B (0.71) IL1BTNFNLRP3
SCHEMBL30833885 0.87 IL1B (0.72) IL1BTNFNLRP3
SCHEMBL31681927 0.85 IL1B (0.70) IL1BTNFNLRP3
SCHEMBL22654972 0.83 IL1B (1.00) IL1BTNFNLRP3
SCHEMBL22689607 0.83 IL1B (1.00) IL1BTNFNLRP3
SCHEMBL22654986 0.83 IL1B (1.00) IL1BTNFNLRP3
SCHEMBL22689606 0.83 IL1B (1.00) IL1BTNFNLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4433459-A1 PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3 F. Hoffmann-La Roche AG (CH) 2024-09-25 EP claimed
CN-118265701-A Pyridazine derivatives as inhibitors of NLRP3 豪夫迈·罗氏有限公司 2024-06-28 CN claimed
WO-2023088987-A1 PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3 F. HOFFMANN-LA ROCHE AG (CH) 2023-05-25 WO claimed
EP-4433459-A1 PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3 F. Hoffmann-La Roche AG (CH) 2024-09-25 EP disclosed
CN-118265701-A Pyridazine derivatives as inhibitors of NLRP3 豪夫迈·罗氏有限公司 2024-06-28 CN disclosed
WO-2023088987-A1 PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3 F. HOFFMANN-LA ROCHE AG (CH) 2023-05-25 WO disclosed